Magadmi, R.; Alharthi, A.M.; Alqurashi, L.A.; Jali, I.M.; Sharawi, Z.W.; Jamal, M.H.; Bawazir, Y.; Mustafa, M.; Bahlas, S.M.; Jamal, B.T.;
et al. Association of SLCO1B3 and SLCO1B1 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals 2025, 18, 1069.
https://doi.org/10.3390/ph18071069
AMA Style
Magadmi R, Alharthi AM, Alqurashi LA, Jali IM, Sharawi ZW, Jamal MH, Bawazir Y, Mustafa M, Bahlas SM, Jamal BT,
et al. Association of SLCO1B3 and SLCO1B1 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals. 2025; 18(7):1069.
https://doi.org/10.3390/ph18071069
Chicago/Turabian Style
Magadmi, Rania, Ahlam M. Alharthi, Lina A. Alqurashi, Ibtisam M. Jali, Zeina W. Sharawi, Maha H. Jamal, Yasser Bawazir, Mohammad Mustafa, Sami M. Bahlas, Basma T. Jamal,
and et al. 2025. "Association of SLCO1B3 and SLCO1B1 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients" Pharmaceuticals 18, no. 7: 1069.
https://doi.org/10.3390/ph18071069
APA Style
Magadmi, R., Alharthi, A. M., Alqurashi, L. A., Jali, I. M., Sharawi, Z. W., Jamal, M. H., Bawazir, Y., Mustafa, M., Bahlas, S. M., Jamal, B. T., Daghasi, H., Altowairqi, A. S., & Al Shaer, D. S.
(2025). Association of SLCO1B3 and SLCO1B1 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients. Pharmaceuticals, 18(7), 1069.
https://doi.org/10.3390/ph18071069
